title: Metabolism of surfactant phosphatidylcholine molecular species in cftr(tm1HGU/tm1HGU) mice compared to MF-1 mice.
abstract: In cftr(tmIHGU/m1HGU) mice, an animal model designed to study pathophysiologic alterations due to the CFTR defect found in cysticfibrosis, surfactant phospholipids of bronchoalveolar lavage fluid (BALF) are increased. To study the metabolical basis of such increases, we intraperitoneally injected cft(tm1HGU/tm1HGU) mice [methyl-3H]choline and measured [methyl-3H]choline incorporation into phosphatidylcholine (PC) molecular species of lung tissue and BALF after 1.5 to 24 hours. MF1 and MF1 x cftr(tm1HGU/tm1HGU) hybrid mice served as controls. In tissue [methyl-3H]choline incorporation into total PC was constant for 24 hours and identical in control and cftr(tmIHGU/m1HGU) mice. However, from 7.5 to 24 hours there was a shift of [methyl-3H]choline incorporation from palmitoyloleoyl-PC and palmitoyllinoleoyl-PC towards PC species enriched in surfactant, dipalmitoyl-PC, palmitoylmyristoyl-PC, and palmitoylpalmitoleoyl-PC. The relative and absolute 3H-labels of PC species were identical for cftr(tmIHGU/m1HGU) compared to control mice. In BALF [methyl-3H]choline of total PC increased from 1.5 to 24 hours (R2 > .98), mainly due to [methyl-3H]choline-labelled dipalmitoyl-PC, in all experimental groups. In BALF from cftr(tmIHGU/m1HGU) mice, the [methyl-3H]choline label of total PC and individual PC species was significantly increased over control values after 24 hours, but not after 1.5 to 6 hours. Numbers and composition of BALF cells were not different between controls and cftr(tmIHGU/m1HGU) mice. We, conclude that increased alveolar phospholipid in cftr(tmIHGU/m1HGU) mice is likely due to decreased reuptake of surfactant.
authors.affiliation: Department of Pediatric Pulmonology and Neonatology, Hannover Medical School, Federal Republic of Germany. Bernhard.Wolfgang@.mh-hannover.de
authors.forename: W
authors.initials: W
authors.lastname: Bernhard
authors.forename: A
authors.initials: A
authors.lastname: Bertling
authors.forename: H
authors.initials: H
authors.lastname: Dombrowsky
authors.forename: G
authors.initials: G
authors.lastname: Vieten
authors.forename: G
authors.initials: G
authors.lastname: Rau
authors.forename: H
authors.initials: H
authors.lastname: von der Hardt
authors.forename: J
authors.initials: J
authors.lastname: Freihorst
mesh_terms: D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D003550:Cystic Fibrosis / Q000235:genetics / Q000378:metabolism; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics* / Q000378:metabolism; D004195:Disease Models, Animal; D006801:Humans; D007700:Kinetics; D008168:Lung / Q000378:metabolism; D051379:Mice; D008817:Mice, Mutant Strains; D010713:Phosphatidylcholines / Q000737:chemistry / Q000378:metabolism*; D011663:Pulmonary Surfactants / Q000737:chemistry / Q000378:metabolism*; D014316:Tritium
chemical_list: C505032:CFTR protein, human; D010713:Phosphatidylcholines; D011663:Pulmonary Surfactants; D014316:Tritium; D019005:Cystic Fibrosis Transmembrane Conductance Regulator